7/1/2011

Generic-drug maker Impax Laboratories resolved a patent dispute with Genzyme and Daiichi Sankyo regarding diabetes pill Welchol. The settlement allows Impax to market its version on March 2, 2015, or earlier under certain conditions.

Full Story:
Reuters

Related Summaries